CLDN5 and Hyperglycemia: Experimental evidence demonstrates that hyperglycemia and pro-inflammatory cytokines synergistically degrade these junctional complexes [15,16], particularly through the downregulation of Cldn5 (essential for barrier selectivity) and Ocln (critical for junction assembly) [17,18].